dotatate 90y
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 2004 (NCT04029428)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 90-yttrium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04029428 | Phase 2 | Nov 2, 2004 | Association of Patients and Supporters of Neuroendocrine Tumors, Warsaw, Poland, University of Warmia and Mazury |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Association of Patients and Supporters of Neuroendocrine Tumors, Warsaw, Poland | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Warmia and Mazury | Academic/Hospital | 1 | 1 | 1 | 2004 |
2 organizations
Page 1 / 1